Details of the Drug

General Information of Drug (ID: DMA17CT)

Drug Name

Imlygictalimogene laherparepvec

Indication

Disease Entry	ICD 11	Status	REF
Peripheral nervous system tumour	2B5E	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)